Name: UMIN ID:
Unique ID issued by UMIN | UMIN000013588 |
---|---|
Receipt number | R000015877 |
Scientific Title | Phase II trial of GDP therapy (gemcitabine, cisplatin and dexamethasone) in patients with refractory or recurrence non-Hodgkin's lymphoma having a history of more than 2 regimens. |
Date of disclosure of the study information | 2014/04/01 |
Last modified on | 2018/04/04 15:16:53 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/04/01 11:17:48 | ||
2 | Update | 2018/04/04 15:16:53 | Recruitment status |